Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
Clinical trial NCT06027853 · RECRUITING
Trial details
- NCT number
- NCT06027853
- Sponsor
- Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-10
- Primary completion
- 2026-08-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.